Search

Clinical Articles / BY: Michelle Fung, MD, FRCPC November 2004
... group compared with the conventional therapy group (7.2% vs 9.1%, P<.001). The two target populations in the ... that observed in the conventionally treated subjects.  [7]  Another undesirable effect of intensive insulin therapy ... kg) than subjects receiving standard therapy (2.4 +/- 3.7 kg,  P <.0001) during the first year of therapy. [8]  The ...
Clinical Articles / BY: Nita Jain, MD, FRCPC April 2004
... is common. [4]  The incubation period is usually 2 to 7 days. [4]  In prepubertal girls, the lack of ... (50 mg/kg, maximum, 2 g) in 4 divided doses per day for 7 days, or azithromycin (20 mg/kg, maximum, 1 g) in a single dose. [4,7] Chlamydia Chlamydia trachomatis  is an obligate ...
Clinical Articles / BY: C.L. Davies September 2004
... diagnosis, selecting a treatment becomes guesswork. Deyo [7]  describes the history of the treatment of low back pain ...
Clinical Articles / BY: Margaret Colbourne, MD, FRCPC March 2004
... in Canada annually, with a mortality rate of almost 20%. [7]  Unfortunately, many cases of abusive head trauma often ... health problems, and only 22% appeared well at discharge. [7]  Other data indicate that some children may have a ...
Clinical Articles / BY: W. Alan Dodd, MD, FRCPC December 2004
... scratching, and hear the complaints of itching ( Figure 7 ). Often scratching of pruritic skin can induce secondary ... usual for the patient to receive a second treatment 5 to 7 days later. Specific antiscabietic agents Currently, ... were available. It is applied twice daily for 5 to 7 days. Nonspecific management of scabies While specific ...
BC Centre for Disease Control / BY: M. Fyfe, MD, MSc June 2004
... serum collected 14 days to 21 days later. Serum (7 mL to 10 mL) should be collected in a pink-top tube and ... • Acute plasma collected on presentation. Plasma (7 mL to 10 mL) should be collected in a purple-top tube and ...
Clinical Articles / BY: Michelle Fung, MD, FRCPC November 2004
... insulin independence rates reported at less than 10%. [7]  Fortunately, significant progress has since been made in ...
Letters / BY: John R. McLeod, MD April 2004
... program [see BCMJ  2003;45:391–394  and  2004; 46:7–9 ]. The main reason is the changes that have occurred ...
Clinical Articles / BY: Charmaine Kim-Sing, MD, ChB, FRCPC October 2004
... a greater than 90% reduction in breast cancer risk. [7]  No recommendation is made for or against prophylactic ... Placebo group  Tamoxifen group 40 – 49 1.5 6.7 3.77 50 – 59 2.5 6.28 3.10 ≥60 3.5 7.33 3.33 Any age, with lobular carcinoma in situ N/A 12.99 ...
Clinical Articles / BY: Daniel Lin, BSc May 2003
... used as methods to evaluate treatment interventions. [6,7]  Structured interviews such as these may provide some ...